You are here

  • Home
  • Archive
  • Volume 77, Issue 12
  • Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial

Citation Tools

Article menu

Download PDFPDF

Clinical and epidemiological research
Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Kaneko Y, Kameda H, Ikeda K, et al
Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial
Annals of the Rheumatic Diseases 2018;77:1720-1729.